E-LIB Suche - Ergebnisse für: Petrylak, D.P

1

TROPHY-U-01, a phase II open-label study of sacituzumab gov..:

Loriot, Y. ; Petrylak, D.P. ; Rezazadeh Kalebasty, A....
Annals of Oncology. 35 (2024) 4 - p. 392-401 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy and safety of pembrolizumab in metastatic urotheli..:

Balar, A.V. ; Castellano, D.E. ; Grivas, P....
Annals of Oncology. 34 (2023) 3 - p. 289-299 , 2023

Link: https://doi.org/10.1016/..

3

A randomized phase IIa study of quantified bone scan respon..:

Petrylak, D.P. ; Vaishampayan, U.N. ; Patel, K.R....
ESMO Open. 6 (2021) 2 - p. 100082 , 2021

Link: https://doi.org/10.1016/..

4

Randomized phase III KEYNOTE-045 trial of pembrolizumab ver..:

Fradet, Y. ; Bellmunt, J. ; Vaughn, D.J....
Annals of Oncology. 30 (2019) 6 - p. 970-976 , 2019

Link: https://doi.org/10.1093/..

5

Activity of the FGFR1–3 inhibitor infigratinib in patients ..:

De Giorgi, U. ; Pal, S.K. ; Rosenberg, J.E....
European Urology Supplements. 18 (2019) 11 - p. e3405-e3406 , 2019

Link: https://doi.org/10.1016/..

6

Phase I/II trial of cabazitaxel plus abiraterone in patient..:

Massard, C. ; Mateo, J. ; Loriot, Y....
Annals of Oncology. 28 (2017) 1 - p. 90-95 , 2017

Link: https://doi.org/10.1093/..

7

2508 Three-arm phase II randomized trial of docetaxel monot..:

Petrylak, D.P. ; Tagawa, S.T. ; Kohli, M....
European Journal of Cancer. 51 (2015) - p. S476 , 2015

Link: https://doi.org/10.1016/..

8

419 Androgen receptor (AR) and AR-V7 expression in circulat..:

Petrylak, D.P. ; DiPippo, V.A. ; Werner, S.L....
European Journal of Cancer. 51 (2015) - p. S84-S85 , 2015

Link: https://doi.org/10.1016/..

9

Time to disease-related pain and first opioid use in patien..:

Small, E J ; Higano, C S ; Kantoff, P W...
Prostate Cancer and Prostatic Diseases. 17 (2014) 3 - p. 259-264 , 2014

Link: https://doi.org/10.1038/..

10

123 Time to disease-related pain (TDRP) following sipuleuce..:

Small, E.J. ; Higano, C.S. ; Kantoff, P.W....
European Urology Supplements. 11 (2012) 1 - p. e123-e123a , 2012

Link: https://doi.org/10.1016/..

11

565 POSTER Activity of the anti-IGF-IR antibody CP-751,871 ..:

De Bono, J.S. ; Petrylak, D.P. ; Calvo, E....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 178 , 2008

Link: https://doi.org/10.1016/..

12

SATRAPLATIN (S) INCREASES PROGRESSION-FREE SURVIVAL (PFS) A..:

Sternberg, N. ; Sartor, O.A. ; Petrylak, D.P....
European Urology Supplements. 7 (2008) 3 - p. 230 , 2008

Link: https://doi.org/10.1016/..

13

Transferrin Receptor Expression in Testis Cancer:

PETRYLAK, D. P. ; YAGODA, A. ; O'TOOLE, K. M....
JNCI Journal of the National Cancer Institute. 86 (1994) 8 - p. 636-637 , 1994

Link: https://doi.org/10.1093/..

14

P-glycoprotein expression in primary and metastatic transit..:

Petrylak, D.P. ; Scher, H.I. ; Reuter, V...
Annals of Oncology. 5 (1994) 9 - p. 835-840 , 1994

Link: https://doi.org/10.1093/..

15

A Rapid Assay of Suramin in Plasma:

Tong, W. P. ; Scher, H. I. ; Petrylak, D. P....
Journal of Liquid Chromatography. 13 (1990) 11 - p. 2269-2284 , 1990

Link: https://doi.org/10.1080/..